HealthWarehouse.com, Inc. (HEWA)
| Previous close | 0.1190 |
| Open | 0.1190 |
| Bid | 3.5000 x 500 |
| Ask | 4.7500 x 500 |
| Day's range | 0.1190 - 0.1190 |
| 52-week range | 0.1000 - 0.2300 |
| Volume | |
| Avg. volume | 2,000 |
| Market cap | 6.507M |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
HealthWarehouse.com Reports Full Year 2023 Results
CINCINNATI, March 25, 2024--HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today its results of operations for the year ended December 31, 2023. The Company reported net sales for the year of $20.3 million, a 12% increase over the year ended December 31, 2022, resulting from 18% growth in direct-to-consumer and partner services prescription revenues, offset in part by a decline in over-the-counter product sales.
- Business Wire
HealthWarehouse.com Reports Results for Third Quarter 2023
CINCINNATI, November 09, 2023--HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2023. The Company reported net sales for the third quarter of 2023 of $4.8 million, a 2% increase over the same period in 2022, resulting from growth in B2C revenue despite a 46% decline in over-the-counter segment of B2C revenue. Prescription revenues increased by 10% during the quarter.
- Business Wire
HealthWarehouse.com Reports Results for Second Quarter 2023
CINCINNATI, August 10, 2023--HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2023. The Company reported net sales for the second quarter of 2023 of $5.3 million, a 27% increase over the same period in 2022, resulting from strong growth in partner services and B2C revenue. The Company reported a net loss of $477,000 for the quarter and a net loss of $825,000 for the six months ended June 30, 2023.
